» Articles » PMID: 18754037

Lack of Evidence for Activation of the Hedgehog Pathway in Psoriasis

Overview
Publisher Elsevier
Specialty Dermatology
Date 2008 Aug 30
PMID 18754037
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Recent reports have suggested that the hedgehog (Hh) pathway is activated in lesional psoriatic skin, and that treatment with the Hh pathway antagonist cyclopamine may lead to rapid resolution of the disease. To assess Hh pathway activity in psoriasis, we isolated RNA from lesional and uninvolved skin of 58 psoriatic patients, and from 63 normal control subjects, and subjected these samples to global gene expression profiling on Affymetrix HU133 Plus 2.0 gene arrays. We were especially interested in Hh target genes (PTCH1 and GLI1), whose expression is elevated in response to Hh signaling. The microarray data demonstrated downregulation of PTCH1 expression in uninvolved and lesional skin (1.1-fold and 2-fold, respectively; P<0.0001). Additionally GLI1 mRNA was downregulated in lesional skin (1.7 fold; P<0.05). No significant changes were observed between lesional and uninvolved skin for the Hh ligands or Smoothened. Quantitative PCR confirmed these findings. In situ hybridization for GLI1 and PTCH1 was positive in basal cell carcinoma tumor cells, but was negligible in uninvolved or lesional psoriatic skin. The absence of elevated Hh target gene expression in lesional psoriatic skin indicates that the Hh pathway is not activated in this disease, raising questions regarding the proposed use of Hh antagonists as antipsoriatic agents.

Citing Articles

IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis.

Mehta N, Teague H, Swindell W, Baumer Y, Ward N, Xing X Sci Rep. 2017; 7(1):13831.

PMID: 29062018 PMC: 5653789. DOI: 10.1038/s41598-017-14365-1.


Immunology of psoriasis.

Lowes M, Suarez-Farinas M, Krueger J Annu Rev Immunol. 2014; 32:227-55.

PMID: 24655295 PMC: 4229247. DOI: 10.1146/annurev-immunol-032713-120225.


Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis.

Johnston A, Xing X, Swindell W, Kochkodan J, Riblett M, Nair R Hum Mol Genet. 2013; 22(9):1807-15.

PMID: 23376980 PMC: 3613166. DOI: 10.1093/hmg/ddt034.


Transcriptome classification reveals molecular subtypes in psoriasis.

Ainali C, Valeyev N, Perera G, Williams A, Gudjonsson J, Ouzounis C BMC Genomics. 2012; 13:472.

PMID: 22971201 PMC: 3481433. DOI: 10.1186/1471-2164-13-472.


Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA).

Suarez-Farinas M, Lowes M, Zaba L, Krueger J PLoS One. 2010; 5(4):e10247.

PMID: 20422035 PMC: 2857878. DOI: 10.1371/journal.pone.0010247.


References
1.
Daya-Grosjean L, Couve-Privat S . Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett. 2005; 225(2):181-92. DOI: 10.1016/j.canlet.2004.10.003. View

2.
Fan H, Khavari P . Sonic hedgehog opposes epithelial cell cycle arrest. J Cell Biol. 1999; 147(1):71-6. PMC: 2164980. DOI: 10.1083/jcb.147.1.71. View

3.
Mullor J, Sanchez P, Ruiz i Altaba A . Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 2002; 12(12):562-9. DOI: 10.1016/s0962-8924(02)02405-4. View

4.
Johansen C, Flindt E, Kragballe K, Henningsen J, Westergaard M, Kristiansen K . Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. J Invest Dermatol. 2005; 124(6):1284-92. DOI: 10.1111/j.0022-202X.2005.23749.x. View

5.
Bowcock A, Shannon W, DU F, Duncan J, Cao K, Aftergut K . Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001; 10(17):1793-805. DOI: 10.1093/hmg/10.17.1793. View